Brief: Saluda Medical Receives U.S. FDA Approval For New Cap24™ Surgical Paddle Lead
30/06/2026 14:58
BRIEF-Saluda Medical Receives U.S. FDA Approval For New Cap24™ Surgical Paddle Lead June 30 (Reuters) - Saluda Medical Inc SLD.AX:
SALUDA MEDICAL RECEIVES U.S. FDA APPROVAL FOR NEW CAP24™ SURGICAL PADDLE LEAD
SALUDA MEDICAL - TO BEGIN PHASED U.S. LAUNCH OF CAP24 PADDLE LEAD IN H2 2026
Source text: ID:nPn3DjcvJa
Further company coverage: SLD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Saluda Medical
See all newsBrief: Saluda Medical Initiates Voluntary Field Action For Certain Evoke® System Devices
Saluda Medical's shares hit record low on Evoke device recall
Australia's Saluda Medical hits record low on voluntary device field action
Brief: Saluda Medical Expands Access To FDA-Approved Closed-Loop Surgical Paddle Lead
Brief: Saluda Medical Appoints Mike Mathias As CEO Replacing Barry Regan